These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 18055027

  • 1. In vivo administration of corticotropin-releasing hormone at remote intervals following ischemia enhances CA1 neuronal survival and recovery of spatial memory impairments: a role for opioid receptors.
    Charron C, Fréchette S, Proulx G, Plamondon H.
    Behav Brain Res; 2008 Mar 17; 188(1):125-35. PubMed ID: 18055027
    [Abstract] [Full Text] [Related]

  • 2. Neuroprotection and functional recovery conferred by administration of kappa- and delta 1-opioid agonists in a rat model of global ischemia.
    Charron C, Messier C, Plamondon H.
    Physiol Behav; 2008 Feb 27; 93(3):502-11. PubMed ID: 18031772
    [Abstract] [Full Text] [Related]

  • 3. Chronic 17beta-estradiol pretreatment and ischemia-induced hippocampal degeneration and memory impairments: a 6-month survival study.
    Plamondon H, Morin A, Charron C.
    Horm Behav; 2006 Sep 27; 50(3):361-9. PubMed ID: 16815389
    [Abstract] [Full Text] [Related]

  • 4. The CRH1 antagonist CP154,526 failed to alter ischemia-induced neurodegeneration and spatial memory deficits in rats but inhibited behavioral activity in the novel open field.
    Plamondon H, Khan S.
    Behav Brain Res; 2006 Jan 06; 166(1):85-92. PubMed ID: 16183143
    [Abstract] [Full Text] [Related]

  • 5. Protection conferred by Corticotropin-releasing hormone in rat primary cortical neurons against chemical ischemia involves opioid receptor activation.
    Charron C, Schock SC, Proulx G, Thompson CS, Hakim AM, Plamondon H.
    Brain Res; 2009 Feb 27; 1257():117-27. PubMed ID: 19146834
    [Abstract] [Full Text] [Related]

  • 6. Cerebral ischemic preconditioning induces lasting effects on CA1 neuronal survival, prevents memory impairments but not ischemia-induced hyperactivity.
    Plamondon H, Davignon G, Khan S, Charron C.
    Behav Brain Res; 2008 May 16; 189(1):145-51. PubMed ID: 18281106
    [Abstract] [Full Text] [Related]

  • 7. Time-dependent changes in CRH concentrations and release in discrete brain regions following global ischemia: effects of MK-801 pretreatment.
    Khan S, Milot M, Lecompte-Collin J, Plamondon H.
    Brain Res; 2004 Jul 30; 1016(1):48-57. PubMed ID: 15234251
    [Abstract] [Full Text] [Related]

  • 8. Food restriction induces long-lasting recovery of spatial memory deficits following global ischemia in delayed matching and non-matching-to-sample radial arm maze tasks.
    Roberge MC, Messier C, Staines WA, Plamondon H.
    Neuroscience; 2008 Sep 22; 156(1):11-29. PubMed ID: 18672030
    [Abstract] [Full Text] [Related]

  • 9. Pre-treatment and post-treatment with alpha-tocopherol attenuates hippocampal neuronal damage in experimental cerebral hypoperfusion.
    Annaházi A, Mracskó E, Süle Z, Karg E, Penke B, Bari F, Farkas E.
    Eur J Pharmacol; 2007 Oct 01; 571(2-3):120-8. PubMed ID: 17597609
    [Abstract] [Full Text] [Related]

  • 10. Delta opioid receptors stimulation with [D-Ala2, D-Leu5] enkephalin does not provide neuroprotection in the hippocampus in rats subjected to forebrain ischemia.
    Iwata M, Inoue S, Kawaguchi M, Kurita N, Horiuchi T, Nakamura M, Konishi N, Furuya H.
    Neurosci Lett; 2007 Mar 13; 414(3):242-6. PubMed ID: 17207574
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dietary PUFA supplements reduce memory deficits but not CA1 ischemic injury in rats.
    Plamondon H, Roberge MC.
    Physiol Behav; 2008 Oct 20; 95(3):492-500. PubMed ID: 18700150
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Changes in HPA reactivity and noradrenergic functions regulate spatial memory impairments at delayed time intervals following cerebral ischemia.
    Milot MR, Plamondon H.
    Horm Behav; 2011 Apr 20; 59(4):594-604. PubMed ID: 21376725
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Transgenic overexpression of corticotropin releasing hormone provides partial protection against neurodegeneration in an in vivo model of acute excitotoxic stress.
    Hanstein R, Lu A, Wurst W, Holsboer F, Deussing JM, Clement AB, Behl C.
    Neuroscience; 2008 Oct 15; 156(3):712-21. PubMed ID: 18708129
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.